Skip to main content
All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · medical technology association

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 20, 2026

Official filing document

 Bills named in this filing 4
  • HR 5343
    Ensuring Patient Access to Critical Breakthrough Products Act
  • HR 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
  • HR 8800
    National Defense Authorization Act for Fiscal Year 2027
  • S 4784
    National Defense Authorization Act for Fiscal Year 2027
 Lobbying activity 5
Health Issues

General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Issues related to cybersecurity of medical devices manufactured in China. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Medicare/Medicaid

General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Trade (domestic/foreign)

Policies impacting the supply chain and manufacturing of medical devices and technology including tariffs.

Budget/Appropriations

Discussions regarding implementation of medtech related provisions; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260).

Defense

Policies impacting third party repair of medtech. Issues related to competitive bidding in the FY2027 National Defense Authorization Act (H.R.8800/S.4784).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem